ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 203 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $564,213 | +0.8% | 1,312 | -7.7% | 0.00% | – |
| Q1 2024 | $559,869 | +22.0% | 1,422 | +17.9% | 0.00% | – |
| Q4 2023 | $458,798 | -30.4% | 1,206 | -10.1% | 0.00% | -100.0% |
| Q3 2023 | $659,275 | +34.6% | 1,341 | +6.7% | 0.00% | – |
| Q2 2023 | $489,890 | +22.7% | 1,257 | +17.3% | 0.00% | – |
| Q1 2023 | $399,405 | -5.3% | 1,072 | -3.7% | 0.00% | – |
| Q4 2022 | $421,639 | +7.8% | 1,113 | +0.6% | 0.00% | – |
| Q3 2022 | $391,000 | +12.0% | 1,106 | +20.1% | 0.00% | – |
| Q2 2022 | $349,000 | +59.4% | 921 | +32.9% | 0.00% | – |
| Q1 2022 | $219,000 | +87.2% | 693 | +105.6% | 0.00% | – |
| Q4 2021 | $117,000 | -0.8% | 337 | -14.5% | 0.00% | – |
| Q3 2021 | $118,000 | +15.7% | 394 | +16.2% | 0.00% | – |
| Q2 2021 | $102,000 | +72.9% | 339 | +59.9% | 0.00% | – |
| Q1 2021 | $59,000 | +59.5% | 212 | +69.6% | 0.00% | – |
| Q4 2020 | $37,000 | +3600.0% | 125 | +4066.7% | 0.00% | – |
| Q3 2020 | $1,000 | -87.5% | 3 | -94.7% | 0.00% | – |
| Q2 2019 | $8,000 | – | 57 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
| Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
| Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
| MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
| AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
| EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
| INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
| Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
| DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
| Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |